Karyopharm Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). 

CEO
Richard A. Paulson
CEORichard A. Paulson
Employees
442
Employees442
Headquarters
Newton, Massachusetts
HeadquartersNewton, Massachusetts
Founded
2008
Founded2008
Employees
442
Employees442

KPTI Key Statistics

Market cap
401.72M
Market cap401.72M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.46M
Average volume1.46M
High today
$4.96
High today$4.96
Low today
$4.80
Low today$4.80
Open price
$4.89
Open price$4.89
Volume
403.36K
Volume403.36K
52 Week high
$14.73
52 Week high$14.73
52 Week low
$4.00
52 Week low$4.00

Analyst ratings

56%

of 9 ratings
Buy
44.4%
Hold
55.6%
Sell
0%

KPTI Earnings

-$0.77
-$0.36
$0.05
$0.46
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 7, After Hours
ActualExpected Feb 7, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.